- CA$493.10m
- CA$3.79bn
- CA$704.16m
- 96
- 95
- 28
- 84
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 911 | 820 | 758 | 759 | 704 |
Cost of Revenue | |||||
Gross Profit | 874 | 787 | 728 | 705 | 666 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 433 | 415 | 349 | 356 | -94.8 |
Operating Profit | 478 | 405 | 409 | 403 | 799 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 202 | 241 | 233 | -30.2 | 673 |
Provision for Income Taxes | |||||
Net Income After Taxes | 187 | 246 | 162 | -81.6 | 583 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 187 | 246 | 92.5 | -23.8 | 157 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 187 | 246 | 92.5 | -23.8 | 173 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.16 | 4.93 | 2 | -7.58 | 2.76 |
Special Dividends per Share |